Serum Neurofilament Light Level May Predict MS Progression :

High serum levels of neurofilament light are associated with an increased risk for disease progression at 2 years. Clinical, MRI, and OCT measures are not associated with this risk, however.

Related Keywords

Norway , Oslo , Canada , Toronto , Ontario , Berlin , Germany , Barcelona , Comunidad Autonoma De Cataluna , Spain , E Ann Yeh , Synne Brune , Research In Multiple Sclerosis , Neuroinflammatory Disorders Program , Oslo University Hospital , University Of Oslo , European Committee For Treatment , Medscape Medical , European Committee , Multiple Sclerosis , Toward Clinical Practice , Sick Children , Relapsing Remitting Multiple Sclerosis , Arms , Ultiple Sclerosis Relapsing Remitting , Primary Progressive Multiple Sclerosis , Pms , Multiple Sclerosis Imaging , S Imaging , Maging In Multiple Sclerosis , Maging In Ms , Maging Studies In Multiple Sclerosis , Maging Studies In Ms , Ms Lesion , Ultiple Sclerosis Lesion , Multiple Sclerosis Prognosis , S Prognosis , Ultiple Sclerosis Prognostic Factors , ,